The coronavirus vaccine developed by Pfizer and BioNTech has been shown to be 90% effective.
Phase 3 of the Pfizer trial involved 43,538 participants. The latter received two doses of vaccine or a placebo reports Skynews. 90% were protected against the virus within 28 days of the vaccine.
Only 94 people who participated in the trial developed coronavirus and no serious threats to their health have been reported.
“Today is a great day for science and humanity. The first set of results from our covid-19 vaccine trial provide the first evidence of our vaccine’s ability to prevent Covid-19, ”said Pfizer President and CEO Dr Albert Bourla.
“With today’s news, we are taking an important step towards providing the world with an essential vaccine to help end this global health crisis,” he added.
The vaccine from Pfizer and BioNTech is one of many vaccines developed around the world in the race to end the global pandemic.